If you need help accessing our website, call 855-698-9991
Skip to main content

Venous Thromboembolic Center

We have several locations in Manhattan.

Doctors from NYU Langone’s Venous Thromboembolic Center provide immediate and life-saving treatment for people who develop blood clots in their veins, a condition called venous thrombosis, as well as follow-up care for those at risk of this serious condition. 

Blood clots can develop after surgery or injury, during pregnancy, or as a result of an underlying disease, such as cancer, heart disease, or COVID-19. Deep vein thrombosis occurs when a blood clot forms in a deep vein, usually in the leg. If left untreated, a clot can break loose and travel through the bloodstream to the lungs, which can lead to a life-threatening condition known as pulmonary embolism.

Our rapid response team provides timely, efficient treatment for people with blood clots who come into the Ronald O. Perelman Center for Emergency Services. We also closely monitor all patients at Tisch Hospital and Kimmel Pavilion who are receiving treatment for blood clots, and offer follow-up care after discharge from the hospital or emergency department.

Treatment can include medications to thin the blood and break up clots, and surgery to remove or dissolve a clot. Surgeries take place at Kimmel Pavilion, which is equipped to allow traditional surgery and image-guided transcatheter procedures to happen simultaneously and in one place. This allows us to safely treat the most complex blood clots and limits the need for multiple surgeries, allowing people to go home more quickly and experience a faster recovery.

Our team includes experts in cardiology, critical care, emergency medicine, interventional radiology, maternal–fetal medicine, neurosurgery, and vascular surgery. After treatment, our team provides follow-up care to help prevent future blood clots. 

Research and Education

Our doctors are leaders in advancing the understanding of venous thromboembolism and in research into the latest treatments. This gives our patients access to therapies currently only available through clinical trials. It also helps us develop new techniques for preventing blood clots, such as understanding the factors that increase a person’s risk. We are also working on developing a blood test that will assess a person’s risk for future clots.